About Aaron Tabor
Form D filings for GENIE Therapeutics in 2023 list Aaron Tabor as chief executive officer.
Aaron Tabor first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Aaron Tabor in the role, so the role may have started earlier or lasted longer.